arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

Ingevity Corp

NGVT
$63.83 ▼ -9.89 (-13.42%) at close
Materials ·Chemicals & Allied Products ·USChemicals & Allied Products
13 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
58
Health
Fair
Neutral
auto_awesome

Analytical Summary

Ingevity Corp shows mixed fundamentals. On the positive side, Operating Margin (%) remains strong. Consider comparing against peers in the Materials sector before making investment decisions.

Market Cap $2.3B
Dividend Yield —
Revenue Growth -2.7% ↗
Op. Margin 35.9% →
ROIC 1491.1% ↗
FCF / Share $9.14 ↗
Trailing P/E —
Price / Book 76.3x
FCF Yield 14.3%
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

13-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.17B
↓ -2.7% —
Net Income Profit after all expenses
$-167.10M
↑ +61.2% —
Operating Margin Operating profit as % of sales
35.9%
↑ +1.0% 91th
FCF / Share Free cash flow per share
$9.14
↑ +158.3% —
trending_up

Bullish Indicators

  • Operating Margin (%)Operating Margin (%) is in the top quartile
warning

Bearish Risks

  • Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑
65
Financial Health ↓
74
Cash Quality
7

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 13 years · 48 quarters